|

Prevalence of Human Papillomavirus (HPV) in a Healthy Population: A Feasibility Study of Oropharyngeal Cancer Screening

RECRUITINGN/ASponsored by The Institute of Molecular and Translational Medicine, Czech Republic
Actively Recruiting
PhaseN/A
SponsorThe Institute of Molecular and Translational Medicine, Czech Republic
Started2025-06-01
Est. completion2030-12-31
Eligibility
Age40 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07033091

Summary

This study defines the prevalence of oral infection with high-risk human papillomaviruses (hrHPV) in individuals over 40 years of age in the Czech Republic. It also establishes an effective methodology for oropharyngeal carcinoma screening and optimization of screening and testing procedures.

Eligibility

Age: 40 Years+Healthy volunteers accepted
Inclusion Criteria:

* Participants aged 40 years or older at the time of enrollment.
* Individuals who are capable of rinsing the oral cavity by gargling independently.
* Signed informed consent for study participation, molecular-genetic testing, and personal data processing.

Exclusion Criteria:

\- Previously diagnosed head and neck cancer.

Conditions2

CancerOropharynx Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.